CD22 MicroBeads were developed for the positive selection or depletion of mouse B cells from peripheral blood and various tissues such as bone marrow, lymph nodes, and spleen.
CD22 MicroBeads were developed for the positive selection or depletion of mouse B cells from peripheral blood and various tissues such as bone marrow, lymph nodes, and spleen.
CD22 is expressed on B lineage cells throughout their development from the early pro-B cell stages onwards and is down-regulated upon terminal differentiation to plasma cells.
For positive selection: MS, LS, XS, or autoMACS® Columns. For depletion: LD, D, or autoMACS Columns.
Separation of CD22+ B cells from spleen suspension using CD22 MicroBeads, an MS Column, and a MidiMACS™ Separator. Cells were fluorescently stained and analyzed by flow cytometry using MACSQuant® Analyzer. Cell debris and dead cells were excluded from the analysis based on scatter signals and propidium iodide fluorescence.